Top Markets
#1 Siren Siren +39.19%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.65%
#3 Ocean Protocol Ocean Protocol +17.20%
#4 KUB Coin KUB Coin +14.89%
#5 Audiera Audiera +11.92%
#6 Perle Perle +10.80%
#7 Arowana Arowana +9.87%
#8 Geodnet Geodnet +9.30%
#9 Nockchain Nockchain +9.22%
#10 Wiki Cat Wiki Cat +8.40%
Coin of the day
Siren Siren
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Antibe Therapeutics Inc. Antibe Therapeutics Inc.

Antibe Therapeutics Inc.

ATE
शेयरों में रैंक #32097
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
शेयर मूल्य
$0.21483059
अंतिम समन्वयन: 2024-05-07
मार्केट कैप
$11.13M
बदलाव (1 दिन)
0.34%
बदलाव (1 वर्ष)
0.00%
देश
CA
व्यापार Antibe Therapeutics Inc. (ATE)

श्रेणी

Healthcare
Antibe Therapeutics Inc. (ATE) के लिए P/S अनुपात
2026 को P/S अनुपात TTM: 0
Antibe Therapeutics Inc. की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/S अनुपात (TTM) 0 है। 2026 के अंत में, कंपनी का P/S अनुपात 0 था।
Antibe Therapeutics Inc. के लिए 2026 से 2026 तक P/S अनुपात का इतिहास
हर वर्ष के अंत में P/S अनुपात
वर्ष P/S अनुपात परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।
समान कंपनियों या प्रतिस्पर्धियों के लिए P/S अनुपात
कंपनी P/S अनुपात P/S अनुपात में अंतर देश
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
4.13 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
5.03 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.67 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
8.10 -
US